Viatrexx-GI

Product NDC
63776-189
Requested package NDC
63776-189-16
11-digit product format
637760189
Labeler code
63776
Product ID
63776-189_e73f8987-8244-4948-adc1-0e9d09497625
Type
HUMAN OTC DRUG
Nonproprietary name
Anti-Interleukin 1, Ankle Articulations, Beta Endorphin, bFGF, Calcaneal tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming GF-Beta
Dosage form
SPRAY
Route
ORAL; TOPICAL
Labeler
VIATREXX BIO INCORPORATED
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2019-03-29
Marketing end
0000-00-00
Substance
ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; MILK THISTLE; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; SUS SCROFA COLON; BOS TAURUS COLON; FRANGULA ALNUS BARK; INTERLEUKIN-12 HUMAN; INTERFERON GAMMA-1A; POTASSIUM CARBONATE; SODIUM CARBONATE; NIACIN; STRYCHNOS NUX-VOMICA SEED; PANTOTHENIC ACID; BOS TAURUS PEYER'S PATCH; SUS SCROFA PEYER'S PATCH; SUS SCROFA RECTUM; SEROTONIN; TARAXACUM OFFICINALE; THIAMINE; VITAMIN D
Active strength
30 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63776-18963776-189-16IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cf050ccd-1144-f76a-e00d-e5698d8597d4Product name620250625
e2dae634-14ed-febf-08ee-93196433b5b7Product name920190614
0a5e5249-329b-0cff-e714-77159f193a87Product name120140508
6b7a6f32-42a6-994d-5ab6-d180e92ee9d8Product name120140508
d394f843-7479-dc48-dbd3-232266c5548cProduct name120140508
dc9a5fb6-14e2-1cc8-a567-a781fd1f0212Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63776-189-11Viatrexx-GI0.5 mL in 1 AMPULESPRAY0.51
63776-189-11Viatrexx-GI1 in 1 BOXSPRAY11
63776-189-14Viatrexx-GI1 in 1 BOXSPRAY11
63776-189-14Viatrexx-GI30 mL in 1 BOTTLE, SPRAYSPRAY301
63776-189-15Viatrexx-GI50 mL in 1 BOTTLE, SPRAYSPRAY501
63776-189-15Viatrexx-GI1 in 1 BOXSPRAY11
63776-189-16Viatrexx-GI1 in 1 BOXSPRAY11
63776-189-16Viatrexx-GI100 mL in 1 BOTTLESPRAY1001
63776-189-17Viatrexx-GI1 in 1 BOXSPRAY11
63776-189-17Viatrexx-GI250 mL in 1 BOTTLESPRAY2501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63776-189VIATREXX-GI (ANTI-INTERLEUKIN 1, ANKLE ARTICULATIONS, BETA ENDORPHIN, BFGF, CALCANEAL TENDON, HIP ARTICULATION, KNEE ARTICULATION, LIVER, TRANSFORMING GROWTH FACTOR-1, TRANSFORMING GF-BETA) SPRAY [VIATREXX BIO INCORPORATED]1Legacy NDC, 10 package rows20210124_2e8c2a20-69f0-4705-a722-9e40870c8e5b.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63776-189-16637760189161 BOTTLE in 1 BOX (63776-189-16) > 100 mL in 1 BOTTLE1 bottle2019-07-050000-00-00NoNoCurrent